Vaccine-induced seroconversion in participants in the North Carolina COVID-19 community Research Partnership

Well-regulated clinical trials have shown FDA-approved COVID-19 vaccines to be immunogenic and highly efficacious. We evaluated seroconversion rates in adults reporting ≥ 1 dose of an mRNA COVID-19 vaccine in a cohort study of nearly 8000 adults residing in North Carolina to validate immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedman-Klabanoff, DeAnna J., Tjaden, Ashley H., Santacatterina, Michele, Munawar, Iqra, Sanders, John W., Herrington, David M., Wierzba, Thomas F., Berry, Andrea A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464595/
https://www.ncbi.nlm.nih.gov/pubmed/36117003
http://dx.doi.org/10.1016/j.vaccine.2022.09.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464595/
https://www.ncbi.nlm.nih.gov/pubmed/36117003
http://dx.doi.org/10.1016/j.vaccine.2022.09.021

Ejemplares similares